Staff & Good Pharma Scorecard Team

Jennifer E. Miller, PhD

Founder, Bioethics International and Good Pharma Scorecard; Co-Director, Yale Program for Biomedical Ethics; Associate Professor, Yale School of Medicine

Joseph S. Ross, MD, MHS

Co-Investigator, Good Pharma Scorecard; Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management)

Michelle Mello, JD, PhD

Co-Investigator, Good Pharma Scorecard; Professor of Health Policy, Professor of Law, Stanford University

Cary Gross, MD

Co-Investigator, Good Pharma Scorecard; Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases), Yale School of Medicine

Tanvee Varma, MD

Researcher, Good Pharma Scorecard; Resident, Brigham and Women's Hospital

William Pelletiers, MPH

Data analyst, Good Pharma Scorecard, Oxford University

Sakinah Carter Suttiratana, PhD

GPS Positive Deviance Study; Co-Director, Yale Center for Community Engagement and Health Equity

Chris Lee

Research Assistant, GPS Test-sell

Ashley Kim, MPH

Senior Manager, Bioethics International

Board of Directors and Advisors

Jennifer E. Miller, PhD

Founder, Bioethics International
Assistant Professor, Yale University School of Medicine

Wilco Faessen

Senior managing director, Strategic advisory practice; Co-head, Consumer retail group, Evercore; Chairman and founder; WhistlePig

Marie-Catherine Letendre, PhD

Theology, Ursuline Academy of Dallas; President, Venetiae Incipit Scriptorium (calligraphy & media arts society)

Liam O’Brien, Esq

Managing Partner, McCormick & O’Brien LLP

Stephen M. Sammut, MBA, PhD

Senior Fellow, Health Care Management; Wharton School of Business; Chairman, Industry Advisory Board, Alta Semper Capital LLP

Marc Wilenzick, Esq

Associate General Counsel, Gilead

Jeremy Abbate*

Publisher, Scientific American

Tanisha Carino*

EVP, Chief Corporate Affairs Officer, Alexion

Doug Dickerson, MBA*

State Director, AARP

Patrick Jordan, MBA, MA*

Chief Administration Officer, Encore, A Quintiles Company

Llew Keltner, MD, PhD*

CEO, EPISTAT; Professor of Bioethics, Columbia University

Leslie J. Levinson, Esq.*

Partner & Co-chair of Transactional Health Law Group, Robinson+Cole

Mark McClellan, MD, PhD*

Former FDA Commissioner and CMS Administrator
Senior Fellow and Director, Health Care Innovation and Value Initiative, Brookings Institution

Mark R. Mercurio, MD, FAAP*

Director, Yale Pediatric Ethics Program
Co-Chair, Yale-New Haven Hospital Ethics Committee
Professor, Yale School of Medicine

Puru Pathak, MS*

Software Engineer, Cloud Computing, Amazon

Mike Rea*

CEO, IDEA Pharma

Briggs W. Morrison, MD*

CEO, Syndax Pharmaceuticals

Lauren Rogge*

Manager, Climate Change and Sustainability, Ernst & Young

Lucy Rose, MBA*

CEO, Lucy Rose and Associates; Former Director, FDA CDER DDMAC

Richard Wilder*

Associate General Counsel, Gates Foundation

Kimberly Sabelko*

Managing Director, Susan G. Komen for the Cure

Rob Scott, MD*

Retired Chief Medical Officer, Abbvie

Bray Patrick-Lake*

Senior Digital Health Specialist, FDA

Cheryl Pegus, MD*

EVP, Health & Wellness, Walmart
Board Chair, Association of Black Cardiologists
(Advisor on SciAm project)

Jessica Scott, MD*

President, Legacy Health Strategies

Pierre Theodore, MD''

Executive Director Health Equity, Genentech; Clinical Associate Professor of Surgery; Stanford School of Medicine; Board of Directors, Saint Boniface Haiti Foundation

David Leventhal''

Senior Director, Enterprise Clinical Trial Data Sharing Lead, Pfizer

''Bioethics think tank member

*Advisory Board

No one organization brings forward ethical questions to a level easily understood on a daily basis by clinicians and managers alike than Bioethics International. Finally, a mechanism that operationalizes ethics for the clinician!

Frederick M. Burkle, Jr., MD, MPH, DTM, Professor, Sr. Fellow, Harvard Humanitarian Initiative, Harvard University, Cambridge